RecruitingNCT05890365

Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals

Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals - Extended Validation.

Sponsor

Steno Diabetes Center Copenhagen

Enrollment

300 participants

Start Date

Dec 14, 2023

Study Type

OBSERVATIONAL

Conditions

Non-Alcoholic Fatty Liver Disease Low Birth Weight

Summary

The investigators recently demonstrated a increase in liver fat in early middle-aged LBW compared to normal birth weight (NBW) men, and 20% of the LBW - but none of the normal birth weight (NBW) - men had previously unknown non-alcoholic fatty liver disease (NAFLD). Here the investigators will further examine the Increased risk of non-alcoholic fatty liver disease in low birth weight individuals by performing a validation study.

Eligibility

Min Age: 35 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This study looks at whether people who were born with a low birth weight are at higher risk of developing fatty liver disease (NAFLD) later in life, even if they are otherwise healthy. **You may be eligible if...** - You were born at low birth weight (below the 10th percentile for your population) or normal birth weight (50th–90th percentile) - You were born at full term (weeks 39–41) - You are generally healthy **You may NOT be eligible if...** - Your BMI is above 35 - You have a known disease or take medications known to affect liver function Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.